Related Experiment Video

Updated: Jan 18, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.4K

BRAF exon 11 mutant melanoma and sensitivity to BRAF/MEK inhibition: Two case reports

Audrey Melin1, Emilie Routier1, Hubert Tissot2

  • 1Department of Dermatology, Gustave Roussy, 114 Rue Edouard-Vaillant, 94800, Villejuif, France.

European Journal of Cancer (Oxford, England : 1990)
|October 1, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.3K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.5K

Related Experiment Videos

Last Updated: Jan 18, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.4K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.3K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

8.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.0K

Articles linked to this work by shared authors, journal, and citation graph.

Sonoanatomy of the Nose: Anatomic Observation.

The Journal of craniofacial surgery·2026

The SibUS-In Finger Probe: An Alternative Device and Method for Ultrasound-Guided Injections.

Aesthetic surgery journal. Open forum·2026

French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025

Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case report.

Joint bone spine·2025

Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.

Nature medicine·2025

Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation.

PLoS biology·2025

Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns.

European journal of cancer (Oxford, England : 1990)·2026

Thirty years of adjuvant therapy: From treating risk to treating residual disease.

European journal of cancer (Oxford, England : 1990)·2026

Artificial intelligence for brain cancer management: multimodal digital workflows for diagnosis, treatment planning, and longitudinal monitoring.

European journal of cancer (Oxford, England : 1990)·2026

Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma.

European journal of cancer (Oxford, England : 1990)·2026

Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.

European journal of cancer (Oxford, England : 1990)·2026

Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?

European journal of cancer (Oxford, England : 1990)·2026

Efficacy and safety of daratumumab-based quadruplet therapy vs non-daratumumab-based triplet therapy in newly diagnosed multiple myeloma patients: A GRADE assessed systematic review and meta-analysis of randomized controlled trials.

Therapeutic advances in hematology·2026

Targeted AAV gene therapy for neuroblastoma via direct capsid-antibody coupling.

EMBO molecular medicine·2026

Exogenous melatonin alleviates liver injury via regulating hepatocellular PI3K/AKT pathway and inhibiting NLRP3 activation.

European journal of pharmacology·2026

A therapeutic atlas of monogenic inflammatory bowel disease.

Journal of Crohn's & colitis·2026

German Delphi consensus: COMT inhibitors in the management of wearing-off fluctuations in Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Interventional management of acute mesenteric venous thrombosis: a systematic review of current evidence, emerging techniques and future perspectives.

Abdominal radiology (New York)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us